neuroClues

neuroClues is a MedTech company dedicated to the early diagnosis and monitoring of neurological disorders using advanced eye-tracking technology. Founded by a team of researchers, doctors, and engineers, the company aims to enhance neurologic care by providing clinicians with objective biomarkers that can identify conditions like Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis before visible symptoms arise. The flagship product, neuroClues®, is a CE-marked Class IIa medical device designed for clinical use in Europe. This portable headset employs infrared eye-tracking to capture up to 800 images per eye per second, allowing for quick and non-invasive analysis of eye movements. The system provides precise and quantifiable biomarkers of neurological function, making it a valuable tool for neurologists and neuro-ophthalmologists. neuroClues plans to expand its reach to general practitioners and vision professionals, aiming to support over 10 million patients worldwide by 2030-2032. The company is also pursuing regulatory approvals for market expansion in North America and Europe.

• Employees 29
• Founded 2020